Page 12 - Systemic Sclerosis News Today

The recommendations advise on managing cardiovascular health in patients with gout, vasculitis, systemic sclerosis, myositis, Sjögren syndrome, lupus, antiphospholipid syndrome, and other diseases.

In real-world study, stem cell transplant provides major advantages for rapidly progressive systemic sclerosis if strict selection criteria are used.

Two experts from Hospital for Special Surgery review the current landscape and evidence for interstitial lung disease screening in patients with connective tissue diseases.

/PRNewswire/ -- Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX), a specialty pharmaceutical company, announced today that it has entered into and closed on a...

/PRNewswire/ -- Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX), a specialty pharmaceutical company today announced the U.S. Food and Drug Administration (FDA)...

Cumberland Pharmaceuticals Moving Corporate Headquarters to Broadwest NASHVILLE, Tennessee - Broadwest is pleased to announce it has entered into an agreement... | November 20, 2021

/PRNewswire/ -- Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX) announced today that it will release third quarter 2021 financial results and provide a Company...

A recent study discusses the clinical characteristics and outcomes of patients with SARDs who were previously vaccinated against SARS-CoV-2.

Diagnosed prevalent cases of systemic sclerosis will reach 187,000 by 2030, forecasted by GlobalData

Chemomab to Present at Oppenheimers Virtual Rare and Orphan Disease Summit USA - English Share this article Share this article TEL AVIV, Israel, May 12, 2021 /PRNewswire/ -- Chemomab Therapeutics Ltd. (Nasdaq: CMMB), a clinical-stage biotech company focused on the discovery and development of innovative therapeutics for fibrosis-related diseases with high unmet need, today announced that the companys CEO, Dr. Adi Mor will present a corporate update at Oppenheimers virtual Rare and Orphan Diseas...